NovoCure's Asset Writedowns and Impairment fell 4888.89% to $230000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year increase of 26434.11%. This contributed to the annual value of $1.2 million for FY2024, which is 13509.13% up from last year.
NovoCure's Asset Writedowns and Impairment amounted to $230000.0 in Q3 2025, which was down 4888.89% from $424000.0 recorded in Q2 2025.
In the past 5 years, NovoCure's Asset Writedowns and Impairment registered a high of $2.3 million during Q1 2025, and its lowest value of $112000.0 during Q3 2023.
In the last 5 years, NovoCure's Asset Writedowns and Impairment had a median value of $178000.0 in 2021 and averaged $324789.5.
Its Asset Writedowns and Impairment has fluctuated over the past 5 years, first soared by 283333.33% in 2021, then plummeted by 7301.59% in 2023.
Quarter analysis of 5 years shows NovoCure's Asset Writedowns and Impairment stood at $182000.0 in 2021, then soared by 142.31% to $441000.0 in 2022, then crashed by 73.02% to $119000.0 in 2023, then skyrocketed by 215.13% to $375000.0 in 2024, then tumbled by 38.67% to $230000.0 in 2025.
Its Asset Writedowns and Impairment was $230000.0 in Q3 2025, compared to $424000.0 in Q2 2025 and $2.3 million in Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value